Evidence map›Paper›PMID 28472409›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2017

Gait Rather Than Cognition Predicts Decline in Specific Cognitive Domains in Early Parkinson's Disease.

Rosie Morris, Sue Lord, Rachael A Lawson, Shirley Coleman, Brook Galna, Gordon W Duncan, Tien K Khoo, Alison J Yarnall, David J Burn, Lynn Rochester

Open access · bronzeAbstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 2 pooled it
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 2 syntheses or guidelines pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Sonification for Personalised Gait Intervention.Sensors (Basel, Switzerland) · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Rosie MorrisInstitute of Neuroscience.
Sue LordInstitute of Neuroscience.
Rachael A LawsonInstitute of Neuroscience.
Shirley ColemanUK and Industrial Statistics Research Unit.
Brook GalnaInstitute of Neuroscience.
Gordon W DuncanInstitute of Neuroscience.
Tien K KhooSchool of Medicine and Menzies Health Institute Queensland, Griffith University, Australia.
Alison J YarnallInstitute of Neuroscience.
David J BurnInstitute of Neuroscience.
Lynn RochesterInstitute of Neuroscience.
Newcastle Hospitals - Campus for Ageing and Vitality · GBMRC Centre for Regenerative Medicine · GBUniversity of Wollongong · AU

Funding

Parkinson's UK G-1301Parkinson's UK J-0802
6 · The paper itself

Abstract

backgroundDementia is significant in Parkinson's disease (PD) with personal and socioeconomic impact. Early identification of risk is of upmost importance to optimize management. Gait precedes and predicts cognitive decline and dementia in older adults. We aimed to evaluate gait characteristics as predictors of cognitive decline in newly diagnosed PD.

methodsOne hundred and nineteen participants recruited at diagnosis were assessed at baseline, 18 and 36 months. Baseline gait was characterized by variables that mapped to five domains: pace, rhythm, variability, asymmetry, and postural control. Cognitive assessment included attention, fluctuating attention, executive function, visual memory, and visuospatial function. Mixed-effects models tested independent gait predictors of cognitive decline.

resultsGait characteristics of pace, variability, and postural control predicted decline in fluctuating attention and visual memory, whereas baseline neuropsychological assessment performance did not predict decline.

conclusionsThis provides novel evidence for gait as a clinical biomarker for PD cognitive decline in early disease.

Indexed as

CognitionGaitAgedCognitive DysfunctionFemaleHumansMaleParkinson DiseasePredictive Value of TestsBiomarkerDementiaGait

Identifiers

PMID28472409
PMCPMC5861960
OpenAlexW2611126732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.